Country Medical Lead, Malaysia / Singapore

The Country Medical Lead (CML) will be responsible for the delivery of the medical strategy plan and execution of scientific activities in Malaysia and Singapore. (referred to Country thereafter)

The CML will have overall responsibility for ensuring high quality scientific medical input and clinical strategic direction to support the Therapeutic Area teams to deliver growth in the Country.

The CML will provide and ensure medical expertise and guide medical strategy at country level, liaising with Cluster Lead, Global Medical Affairs and pro-actively collaborating cross functionally with multiple areas, including sales & marketing, market access, clinical development, pharmacovigilance and regulatory affairs.

The CML provides leadership to direct reports and wider medical affairs team, setting direction and ensuring team alignment while developing and retaining key talent.

The CML is responsible for increasing scientific credibility and the ethical image of CSL Behring, facilitating and encouraging the Group's product strategy.

The CML must promote, develop, and maintain strong scientific and medical relationships with TLs, Public Health Bodies and other stakeholders such as patient associations, scientific expert associations and regulatory authorities.

The CML will uphold the integrity of the company by being responsible for medical governance at the country level. This role will have responsibility for delivery on Medical Education.

Responsibilities include :

• Provides strategic leadership and shapes a high-performance culture
• Develops strong TL relationships in therapeutic area and works closely with public organizations and external bodies.
• Leads Field Medical Team (MSL) to develop strategy and plans for medical information exchange with TLs, other Key Medical and Scientific external stakeholders and patient advocacy groups.
• Provides medical expertise to marketing, market access, pricing & HEOR, commercial and research project teams, providing input to RWE , clinical research initiatives and promotional and educational materials
• Provides an efficient interface between the local Medical team and the Therapeutic Area teams
• Translates and defines the country medical strategy in accordance with the Global and Country strategy and the regional and local priorities :
• Proactive in identifying emerging trends, integrating them into medical strategic areas, given the stage of product development, business unit / therapeutic areas issues and the market context
• Bring the medical and scientific expertise needed to build local strategic product / franchise plans and therefore Country Medical, and country brand plans in alignment with Global Medical Plan and Global Brand plans respectively.
• Maintains proactive and broad relationships with key contacts in the affiliate’s healthcare environment as part of a coordinated stakeholder plan to secure involvement in stakeholder discussions and to position CSL within key healthcare initiatives within our therapeutic areas. Openly exchanges with external stakeholders to build on innovative concepts
• Leads the medical team to ensure high quality delivery of tangible and actionable scientific evidence for local studies or in collaboration with the global evidence generation group for global studies, to internal and external customers.
• Ensures scientific balance and the ethics, transparency, quality and compliance of all medical activities.
• Ensures compliance with applicable regulations and internal procedures in the context of interactions with health professionals, learned societies or external providers.
• Oversees Medical Signatory for certification of promotional items (where applicable) , hospitality, donations and advisory board compliance with respective country code of Practice and Legislative requirements.

Education, Skills and competencies :

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at .

Our Benefits